Takeda Partners with Twist Bioscience to Expand Biologics Discovery Capabilities

Biopharma

Home » Health and medicine » Biopharma

Neoleukin Therapeutics Announces Pricing of $76.2 Million Public Offering

SEATTLE, July 02, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq: NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein...

Octant

Pharma’s Dirty Secret, And The Synthetic Biology Startup Offering A New Approach

Berkeley Lights Announces Opto™ Antigen-Presenting Bead Kit to Accelerate the Expansion of Antigen-Specific T Cells Used to Develop Cell-Based Therapies

EMERYVILLE, Calif., June 24, 2020 /PRNewswire/ — Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the Opto Antigen-Presenting Bead (APB) kit, a new reagent kit that activates and expands...

Preclinical Data for PRGN-3005 UltraCAR-T® Demonstrate Superior Expansion and Persistence of UltraCAR-T Compared to Traditional CAR-T

Conagen

CONAMAX(TM): Promising Antibody-based Therapy Breakthroughs are Brewing at Conagen

pharma

Five Things Big Pharma—And Its Investors—Could Learn From Synthetic Biology

Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2

FUJIFILM Diosynth Biotechnologies Enters Strategic Partnership With OXGENE™ To Address Supply Bottlenecks In Gene Therapy Development And Manufacturing

Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors

BiomX Announces Positive Topline Data from Phase 1 Study for Lead Candidate BX001 for Acne-Prone Skin

FDA Accepts Investigational New Drug Application for CRISPR/Cas9-Based Sickle Cell Disease Therapeutic Candidate Developed Under Collaboration with Intellia Therapeutics

Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders

Twist Bioscience Announces Availability of Synthetic SARS-CoV-2 RNA Controls

DEINOVE passes the 2nd milestone of the AGIR program and receives €1.5m from Bpifrance

Biomanufacturing and Bioinformatics Innovator Nature’s Toolbox Raises $13M in Series A Funding Round